Older patients with pulmonary hypertension (PH) are more likely to have complex comorbidity than younger patients with pulmonary arterial hypertension (PAH). The best approach to the evaluation and management of these patients is unclear.
We, retrospectively, reviewed the clinical records of patients older than 60 years referred for evaluation for PAH. We recorded patient demographics, comorbidity, functional classification (FC), right heart catheterization data, echocardiographic data, chest radiographic images and pulmonary function results. We recorded the final diagnoses according to World Health Organization (WHO) subgroups and treatment outcomes based on changes in FC.
Ninety-seven records were reviewed in detail. The mean age was 71.2 ± 7.5 years with 66% women. Cardiovascular disease was the most frequent comorbidity. Mean PA pressure by catheterization was 39.5 ± 12.2 mmHg (n = 65). The overall distribution after evaluation included 21 (21.6%) Group 1, 35 (36.1%) Group 2, 16 (16.5%) Group 3, 18 (18.6%) mixed Group 2 and 3, 6 (6.2%) Group 4 and 1 (1%) Group 5 patients. Group 1 patients were treated with PAH specific drug, and 12 patients had an improvement in FC with treatment.
Older patients with suspected PH often have significant cardiovascular and respiratory comorbidity. Comprehensive evaluations are needed to determine the severity of PH and associated diseases and to initiate treatment focused on FC. Patients in WHO Group 2 and mixed Group 2 and 3 were frequently identified and constituted a diagnostic and treatment challenge in this study. Older patients with PAH may benefit from PAH specific drugs.
Key Indexing Terms
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of the Medical Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Update in pulmonary vascular diseases 2014.Am J Respir Crit Care Med. 2015; 192: 544-550
- The Fifth World Symposium on pulmonary hypertension.J Am Coll Cardiol. 2013; 62: D1-D3
- Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.J Am Coll Cardiol. 2009; 54: S85-S96
- Pulmonary hypertension surveillance: United States, 2001 to 2010.Chest. 2014; 146: 476-495
- Pulmonary hypertension in older adults.Clin Chest Med. 2007; 28 ([vi]): 717-733
- Pulmonary hypertension.J Am Med Assoc. 2012; 308: 1366-1374
- Causes of pulmonary hypertension in the elderly.Chest. 2014; 146: 159-166
- Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.Am J Respir Crit Care Med. 2012; 186: 790-796
- Age-associated increases in pulmonary artery systolic pressure in the general population.Circulation. 2009; 119: 2663-2670
- Sex and haemodynamics in pulmonary arterial hypertension.Eur Respir J. 2013; 43: 523-530
- The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension.Chest. 2014; 145: 1230-1236
- Sex-dependent influence of endogenous estrogen in pulmonary hypertension.Am J Respir Crit Care Med. 2014; 190: 456-467
- Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.Chest. 2013; 144: 169-176
- Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.Int J Cardiol. 2013; 168: 871-880
- Unexplained pulmonary hypertension in elderly patients.Chest. 2007; 131: 94-100
- Primary pulmonary hypertension.Ann Intern Med. 1987; 107: 216
- Pulmonary arterial hypertension.Chest. 2010; 137: 376-387
- Pulmonary arterial hypertension in France.Am J Respir Crit Care Med. 2006; 173: 1023-1030
- Prevalence of pulmonary hypertension in the general population: the Rotterdam Study.PLoS One. 2015; 10: e0130072
- The challenge of managing drug interactions in elderly people.Lancet. 2007; 370: 185-191
- Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients.Ther Clin Risk Manag. 2014; 10: 437-448
- The impact of drug-drug interactions on pulmonary arterial hypertension therapy.Pulm Pharmacol Ther. 2014; 28: 1-8
- Clinical pharmacokinetics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension.J Clin Pharmacol. 2012; 52: 1784-1805
- Multimorbidity in older adults with heart failure.Clin Geriatr Med. 2016; 32: 277-289
- Effect of age on phenotype and outcomes in pulmonary arterial hypertension trials.Chest. 2016; 149: 1234-1244
- Health-related quality of life and survival in pulmonary arterial hypertension.Ann Am Thorac Soc. 2016; 13: 31-39
- Five-year outcomes of patients enrolled in the REVEAL Registry.Chest. 2015; 148: 1043-1054
- Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.Chest. 2013; 144: 160-168
- Variability in hemodynamic evaluation of pulmonary hypertension at large referral centers.Pulm Circ. 2014; 4: 679-684
- Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.Am J Respir Crit Care Med. 2000; 161: 487-492
- The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.Am J Respir Crit Care Med. 2012; 186: 428-433
- Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.J Heart Lung Transplant. 2015; 34: 362-368
Published online: August 23, 2017
Accepted: July 19, 2017
Received in revised form: June 21, 2017
Received: December 9, 2016
☆The authors have no financial or other conflicts of interest to disclose.
© Published by on behalf of Southern Society for Clinical Investigation